8-K/A: BioSig Technologies Amends 8-K to Detail Streamex Acquisition, Unveils Tokenized Gold Strategy and Pro Forma Financials

BioSig Technologies, Inc. filed an amended 8-K to provide comprehensive details on its acquisition of Streamex Exchange Corporation, outlining its new blockchain-based real-world asset tokenization business and presenting pro forma financial information.

Summary

• BioSig Technologies, Inc. (BSGM) completed the acquisition of Streamex Exchange Corporation on May 28, 2025, for 109,070,079 exchangeable shares valued at approximately $105.5 million.
• The acquisition introduces a new business segment for BioSig: tokenized finance and real-world asset (RWA) digitization through Streamex, alongside its existing healthcare innovation platforms.
• Streamex is developing a blockchain-based platform for tokenizing RWAs, starting with gold, and aims to generate revenue from issuance fees, trading fees, listing fees, and private placement services.
• For the three months ended March 31, 2025, Streamex generated approximately $200,000 in revenue and incurred a loss of $215,224 CAD, contributing to an accumulated deficit of $1,902,092 CAD.
• Pro forma combined financial statements show a net loss of approximately $(4,429) thousand USD for the three months ended March 31, 2025, and $(19,008) thousand USD for the year ended December 31, 2024.
• The Exchangeable Shares issued to Streamex shareholders are classified as derivative liabilities, valued at $105.5 million, due to variable settlement terms and a 19.99% Nasdaq cap until shareholder approval, which will result in earnings volatility.
• Streamex shareholders are expected to collectively own 75% of the fully diluted common equity of BioSig post-acquisition, with existing BioSig shareholders retaining 25%, subject to stockholder approval.

Sentiment

Score: 3

Explanation: The sentiment is low due to the early stage of the acquired business, significant accumulated losses, substantial dilution for existing shareholders, and a comprehensive list of high-impact risks related to market adoption, regulatory compliance, and operational execution in a nascent and volatile industry. While the strategic diversification is a positive, the immediate financial outlook and inherent uncertainties weigh heavily.

Positives

• The acquisition diversifies BioSig's business into the emerging and potentially high-growth sector of tokenized real-world assets, starting with gold.
• Streamex's business model anticipates multiple fee-based and recurring revenue streams from tokenization, exchange infrastructure, and capital markets access.
• The company plans to scale operations by increasing tokenized gold contracts, launching a secondary marketplace, expanding to other asset classes, and partnering with institutional market participants.

Negatives

• Streamex is a development-stage company with its platform not yet launched or facilitating any asset tokenization or exchange activity.
• Streamex incurred a loss of $1,686,868 CAD for the period from incorporation (April 5, 2024) to December 31, 2024, and an additional loss of $215,224 CAD for the three months ended March 31, 2025.
• The company has an accumulated deficit of $1,902,092 CAD as of March 31, 2025, raising substantial doubt about its ability to continue as a going concern without additional financing.
• The issuance of Exchangeable Shares will result in substantial dilution to existing BioSig stockholders, reducing their ownership and voting power to 25% on a fully diluted basis.
• The Exchangeable Share structure introduces complexity and potential conflicts between Exchangeable Shareholders and BioSig common stockholders.
• The classification of Exchangeable Shares as derivative liabilities will cause significant non-cash gains or losses in earnings, increasing volatility in reported net income or loss.

Risks

• Financial results and stock price may be adversely affected by fluctuations in gold prices and volatility in digital asset markets.
• Gold-linked tokenization and treasury strategy may expose the company to complex liquidity risks across traditional and digital asset markets.
• Operating in a highly competitive gold market with established participants possessing greater resources, regulatory positioning, or brand recognition.
• Evolving regulatory requirements for gold trading and cross-border transactions may increase compliance costs and restrict or delay operations.
• Ability to execute the business plan depends on the successful development, deployment, and commercialization of blockchain-based enterprise solutions, which may not materialize as expected.
• Changes in laws and regulations, including increased regulation of blockchain technologies and digital assets, may adversely affect the business, product development, and compliance obligations.
• The platform may fail to achieve market adoption or effectively address key inefficiencies in traditional gold and commodities markets.
• Gold-focused tokenization strategy will subject the company to enhanced regulatory oversight across securities, commodities, and precious metals regimes.
• Discrepancies between token volume entitlements and actual gold delivery may lead to valuation uncertainty, settlement delays, and reputational harm.
• Concentration of holdings and strategy in gold may amplify risks and expose the company to adverse market and operational developments.
• Gold holdings will be significantly less liquid than cash and may not serve as a reliable source of liquidity.
• Reliance on future gold production contracts exposes token holders to counterparty and delivery risks.
• Freely transferable nature of gold-backed tokens may increase market volatility and limit recourse for token holders.
• Token holders bear the full economic risk of gold price fluctuations and potential non-performance by gold producers.
• Ability to build and scale a community of clients and investor end-users for blockchain-enabled financial services is uncertain.
• Bullion custody infrastructure is not yet operational and may not be finalized in a timely manner or with expected third-party providers.
• May not enter into relationships with LBMA-accredited custodians or vault providers, impacting gold integrity and investor confidence.
• Gold may be held on an unallocated basis, and there is no current mechanism to link tokens to individual bullion bars, introducing custody, transparency, and redemption risks.
• Physical redemption for gold is not currently offered and may never be provided, limiting utility and investor recourse.
• No independent audit process for bullion holdings has been implemented, and timing for audit implementation remains uncertain.
• Insurance coverage on the underlying gold will be arranged by the custodian, but specific coverage terms have not yet been disclosed or finalized.
• In the event of loss, theft, or damage to the gold, recovery of value may depend entirely on the custodian's insurance and operational reliability.
• Tokenholders may rank as unsecured creditors in an insolvency and may be subject to delays or losses in any distribution process.
• Streamex retains centralized control over the token smart contracts, including upgrade authority, which may result in operational or governance risks.
• No live proof-of-reserves dashboard or public confirmation of 1:1 gold backing for tokens at this time.
• Risk of issuing tokens in excess of gold held if smart contract or operational safeguards fail.
• Tokens are expected to be classified as securities, exposing the company to comprehensive and evolving regulatory obligations across multiple jurisdictions.
• No no-action relief or regulatory approvals have been received in the United States or other jurisdictions outside Canada, which may subject the company to enforcement risk.
• AML/KYC compliance infrastructure and enforcement mechanisms may be evolving or incomplete.
• Tokens are not currently listed on any exchange, and no market makers are engaged to provide liquidity or price stability.
• Transferability, lock-up restrictions, or resale mechanics applicable to tokens have not yet been defined.
• If the bullion custodian or Streamex ceases operations, tokenholders may suffer losses and may not recover their full holdings.
• Risk of being deemed an investment company under the Investment Company Act of 1940, which could significantly limit business operations.
• The Share Exchange Transaction is complex and entails risks related to shareholder approvals, Nasdaq listing, dilution, and market acceptance.
• No assurance that the anticipated benefits of the Share Exchange Transaction will be realized.
• Integration of Streamex's operations into BioSig may disrupt ongoing operations and divert management attention.
• Reliance on contingent Exchangeable Shares and related exchange rights could restrict liquidity and complicate capital structure management.
• The success of the combined company depends in part on retaining key personnel of Streamex.
• Regulatory authorities may not agree with the conclusion that the Share Exchange should be accounted for as a business combination with BioSig as the accounting acquirer or that BioSig was not a shell company prior to the transaction.

Future Outlook

The company anticipates continued revenue growth for Streamex following the Share Exchange, supported by increased issuance activity, platform usage, and capital deployment. Streamex's initial product offering is intended to be a tokenized gold financing program, with plans to scale operations by increasing the number and volume of tokenized gold contracts, launching a secondary marketplace, expanding to additional asset classes, and partnering with institutional market participants. The company also intends to scale its internal treasury strategy to redeploy capital across multiple token issuance cycles per year.

Management Comments

• Henry McPhie, co-founder and Chief Executive Officer of Streamex, will be appointed BioSig's new Chief Executive Officer.
• Morgan Lekstrom, co-founder and Chairman of Streamex, will be appointed Chairman of BioSig.

Industry Context

The acquisition positions BioSig to enter the rapidly evolving real-world asset (RWA) tokenization arena, a sector seeing increasing interest from large financial firms. Streamex aims to provide infrastructure for digital tokens backed by tangible commodities, starting with gold, aligning with a broader trend of integrating blockchain capabilities into conventional markets. This move places BioSig in competition with established players like Pax Gold (PAXG) and Securitize, Inc., as well as other RWA tokenization platforms spanning various asset classes.

Comparison to Industry Standards

• Pax Gold (PAXG) issues gold-backed tokens, redeemable one-for-one for physical gold stored in LBMA vaults, with a market capitalization of approximately $810 million. Streamex's tokens are intended to be backed by forward delivery contracts, not direct physical gold, and do not currently offer physical redemption.
• Securitize, Inc., a regulated issuer of security tokens, has enabled over $4 billion in tokenized assets, including tokenized treasury and equity funds, using regulated infrastructure. Streamex is in a development stage and has not yet launched its platform or facilitated any asset tokenization.
• Tradeweb and other institutional platforms are integrating blockchain capabilities into conventional markets, complementing the trend of RWA tokenization. Streamex aims to compete in this space but lacks the established market presence and liquidity of these larger players.
• Unlike traditional gold investment products such as ETFs, futures contracts, and bullion dealers, which are widely accepted, Streamex's platform is new and its commercial acceptance of tokenized commodity assets is uncertain, particularly those not offering direct legal title to physical bullion.

Management Changes

Corporate Governance

Legal Proceedings

• Tokens proposed to be issued through the Streamex platform are expected to be classified as securities under applicable U.S., Canadian, and international securities laws, subjecting the company to comprehensive regulatory compliance.
• The company has not received any no-action relief or regulatory approvals in the United States or other jurisdictions outside Canada, which may subject it to enforcement risk and limit its ability to operate.
• The SEC has taken an expansive view of what constitutes a shell company in transactions involving private companies entering public markets via reverse mergers, and if BioSig were deemed a shell company, it would trigger significant regulatory consequences, including ineligibility for short-form registration statements and limitations on capital raising.

Related Party Transactions

• Streamex incurred $146,276 CAD in consulting fees and $7,500 CAD in accounting fees from related parties for the period ended December 31, 2024.
• As of December 31, 2024, Streamex had an accounts receivable of $15,000 CAD owed from its CEO and an accounts payable of $23,925 CAD owed to a corporation controlled by its CFO.
• During the period ended December 31, 2024, Streamex issued 30,136,717 common shares to directors and officers for proceeds of $189,986 CAD.
• Streamex recognized stock-based compensation totaling $788,500 CAD, representing the difference between the fair value of shares issued and consideration received from founders' shares.
• For the three months ended March 31, 2025, Streamex incurred $35,000 CAD in consulting fees and $7,500 CAD in accounting fees from related parties.
• As of March 31, 2025, Streamex had an accounts receivable of $15,000 CAD owed from its CEO, an accounts payable of $10,478 CAD due to its CEO, and an accounts payable of $36,750 CAD owed to a corporation controlled by its CFO.

Stakeholder Impact

• **Shareholders (Existing BioSig):** Will experience substantial dilution, with their percentage ownership and voting power significantly reduced to 25% on a fully diluted basis. The classification of Exchangeable Shares as derivative liabilities will introduce earnings volatility.
• **Shareholders (Former Streamex):** Will become the majority owners (75% fully diluted) of the combined entity through Exchangeable Shares, but face complexity, potential illiquidity, and restrictions on exchangeability until BioSig stockholder approval.
• **Employees (Streamex):** The success of the combined company depends on retaining key Streamex personnel, indicating potential for integration challenges and attrition risk.
• **Customers/Investors (Streamex Platform):** Will be exposed to significant risks related to gold price volatility, counterparty performance, regulatory uncertainty, and the early-stage nature of the platform, including lack of physical redemption and independent audits.
• **Regulatory Bodies:** The transaction and Streamex's business model are subject to intense scrutiny from securities and commodities regulators (e.g., SEC, CFTC, CSA), potentially leading to increased compliance burdens, enforcement actions, or operational restrictions.

Next Steps

• BioSig will seek stockholder approval for authorization of an amendment to its certificate of incorporation to authorize sufficient common stock for the exchange of Exchangeable Shares and the New Incentive Plan.
• Streamex plans to increase the number and volume of tokenized gold contracts.
• Streamex intends to launch a secondary marketplace to improve token liquidity.
• Streamex plans to expand its platform to support additional asset classes such as industrial metals, energy royalties, and other RWAs.
• Streamex aims to partner with institutional market participants for underwriting, syndication, and capital markets integration.
• Streamex intends to scale its internal treasury strategy, re-deploying capital across multiple token issuance cycles per year.
• Streamex will continue to develop its blockchain-based technology platform, including features like real-time proof-of-reserves dashboards, physical redemption protocols, and third-party custodial integrations.
• BioSig will file an initial listing application for its common stock with Nasdaq, if required by change of control rules.

Key Dates

Recommendation

The acquisition of Streamex represents a significant strategic pivot for BioSig into the high-potential, yet highly speculative, real-world asset tokenization space. While the long-term vision of digitizing commodities like gold is compelling, Streamex is currently a development-stage company with substantial accumulated losses and no established revenue streams from its core platform. The transaction introduces significant dilution for existing BioSig shareholders, complex capital structure issues, and a multitude of regulatory and operational risks inherent in the nascent digital asset industry. Given the early stage of the new business, the substantial financial uncertainties, and the extensive list of unmitigated risks, a 'hold' recommendation is appropriate for existing investors to observe the execution of the new strategy and the resolution of key operational and regulatory hurdles. New investors should approach with extreme caution due to the high-risk profile and speculative nature of the combined entity's future.

Keywords

Real-World Assets, RWA Tokenization, Blockchain, Digital Assets, Gold Tokenization, SEC Filing, 8-K/A, Acquisition, BioSig Technologies, Streamex Exchange Corporation, BSGM, Financial Technology, FinTech, Corporate Governance, Dilution, Regulatory Risk, Smart Contracts, Commodity Trading, Investment Company Act, Nasdaq Listing